Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Human Pathology|April 6, 2016
Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration casesRajni Sharma, Yuting Wang, Li Chen, et al.
American Journal of Cancer Research|April 12, 2022
Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panelsQing Kay Li, Tung-Shing Mamie Lih, Yuefan Wang, et al.
Clinical Proteomics|May 12, 2017
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumorsQing Kay Li, Punit Shah, Yuan Tian, et al.
Frontiers in Oncology|July 29, 2020
Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL)Yangying Zhou, Weiming Yang, Minghui Ao, et al.
Cancer Cytopathology|March 16, 2013
Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinomaQing Kay Li, Summer L Nugent, Joely Straseski, et al.
Theranostics|January 2, 2015
Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancersQing Kay Li, Li Chen, Ming-Hui Ao, et al.
Cancer Cytopathology|June 14, 2017
The critical role of EBUS-TBNA cytology in the staging of mediastinal lymph nodes in lung cancer patients: A correlation study with positron emission tomography findingsMohammed T Lilo, Derek B Allison, Bouchra K Younes, et al.
Cancer Cytopathology|March 24, 2016
Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA casesDerek B Allison, Mohammed T Lilo, Susan Geddes, et al.
Glycobiology|June 8, 2014
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancerXiangchun Wang, Jing Chen, Qing Kay Li, et al.
Human Pathology|April 22, 2014
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancerMing-Hui Ao, Hui Zhang, Lynne Sakowski, et al.
Pageof 10